Effectiveness of nimotuzumab combined with onco-specific treatment in Cuban real-life patients with locally advanced or metastatic esophageal squamous cell carcinoma.
Latest Information Update: 22 Nov 2017
At a glance
- Drugs Nimotuzumab (Primary)
- Indications Oesophageal cancer; Squamous cell cancer
- Focus Therapeutic Use
- 22 Nov 2017 New trial record
- 13 Nov 2017 Results assessing the effectiveness of nimotuzumab combined with onco-specific treatment in Cuban real-life patients with locally advanced or metastatic esophageal squamous cell carcinoma, were published in the Advances in Therapy.